The ServierONE patient support program provides patients with financial assistance and one-on-one support when prescribed a Servier oncology product (Table).
ServierONE Patient Support Services
This program offers several patient support services to help patients throughout their treatment journey.
Free Product Program/Financial Assistance Program
ONE for ALL
This site was designed for patients and their families and provides helpful resources and tools for navigating treatment care, costs, and education. ONE for ALL.
In combination with azacitidine or as monotherapy for the treatment of newly diagnosed acute myeloid leukemia (AML) with a susceptible IDH1 mutation as detected by an FDA-approved test in adults aged ≥75 years, or who have comorbidities that preclude use of intensive induction chemotherapy; treatment of adult patients with relapsed or refractory AML with a susceptible IDH1 mutation as detected by an FDA-approved test; treatment of adult patients with previously treated, locally advanced or metastatic cholangiocarcinoma with an IDH1 mutation as detected by an FDA-approved test